Breast cancer after a negative screen: follow-up of women participating in the DOM Screening Programme.

First-round screening results for women participating in the DOM project (a screening programme for early detection of breast cancer) are described for the age groups 40-49 and 50-64 at entry. In the younger age group, a low pick-up rate (1.96 per 1000) in proportion to the expected incidence rate in the absence of screening (1.46 per 1000) was found. For the older age group, these rates were 4.25 and 2.03, respectively, per 1000. Interval cancers occurred (relatively) more frequently in younger women. After 2 years the ratio between interval-cancers and screen-detected tumours was about 1:1 in the younger age group and 1:2.5 in the older age group. These different results can be caused by too low a sensitivity of mammography and/or a higher tumour growth rate at a young age. The sensitivity of the screen at various periods of follow-up, was compared: a rapidly decreasing sensitivity of mammography was seen for women under the age of 50, in contrast to a slower decrease for women over this age. This rapid decrease may be caused by a relatively high tumour growth rate in younger women.

[1]  M Moskowitz,et al.  Breast cancer: age-specific growth rates and screening strategies. , 1986, Radiology.

[2]  J. Hendriks,et al.  MAMMOGRAPHIC SCREENING AND BREAST CANCER MORTALITY: AGE-SPECIFIC EFFECTS IN NIJMEGEN PROJECT, 1975-82 , 1985, The Lancet.

[3]  N E Day,et al.  Estimating the sensitivity of a screening test. , 1985, Journal of epidemiology and community health.

[4]  R. Greenberg,et al.  Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. , 1986, Cancer research.

[5]  R Holland,et al.  The occurrence of interval cancers in the Nijmegen screening programme. , 1989, British Journal of Cancer.

[6]  L. Tabár,et al.  What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. , 1987, British Journal of Cancer.

[7]  L. Tabár,et al.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.

[8]  N. Day,et al.  EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDY , 1984, The Lancet.

[9]  E. A. Baanders-van Halewijn,et al.  The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. , 1984, Journal of chronic diseases.

[10]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[11]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.